# Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer

> **NCT04845503** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital Heidelberg** · enrollment: 68 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** MR-guided Radiotherapy

## Key facts

- **NCT ID:** NCT04845503
- **Lead sponsor:** University Hospital Heidelberg
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-25
- **Primary completion:** 2023-03-25
- **Final completion:** 2028-03-25
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2026-03-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04845503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04845503, "Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04845503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*